Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
- Reiner MF Center for Molecular Cardiology, Laboratory for Platelet Research, University of Zurich, Schlieren, Switzerland; Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland. Electronic address: martin.reiner@gmx.at.
- Müller D Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Gobbato S Center for Molecular Cardiology, Laboratory for Platelet Research, University of Zurich, Schlieren, Switzerland; Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.
- Stalder O CTU Bern and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
- Limacher A CTU Bern and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
- Bonetti NR Center for Molecular Cardiology, Laboratory for Platelet Research, University of Zurich, Schlieren, Switzerland; Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.
- Pasterk L Center for Molecular Cardiology, Laboratory for Platelet Research, University of Zurich, Schlieren, Switzerland; Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.
- Méan M Division of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland.
- Rodondi N Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
- Aujesky D Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.
- Angelillo-Scherrer A Service and Central Laboratory of Hematology, Lausanne University Hospital, Lausanne, Switzerland.
- Matter CM Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
- Lüscher TF Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom.
- Camici GG Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
- von Eckardstein A Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Beer JH Center for Molecular Cardiology, Laboratory for Platelet Research, University of Zurich, Schlieren, Switzerland; Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland. Electronic address: hansjuerg.beer@ksb.ch.
- 2018-12-16
Published in:
- Thrombosis research. - 2019
Bleeding
Deep vein thrombosis
Pulmonary embolism
Recurrent venous thromboembolism
Trimethylamine-N-oxide
Aged
Aged, 80 and over
Female
Gastrointestinal Microbiome
Humans
Male
Methylamines
Prospective Studies
English
INTRODUCTION
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) correlates with arterial thrombotic events including myocardial infarction and stroke, and mortality. However, the association of TMAO with recurrent venous thromboembolism (VTE) and mortality remains unknown.
METHODS
TMAO plasma levels were assessed by high performance liquid chromatography in 859 patients aged ≥65 years with acute VTE and categorized into low (<2.28 μmol/L), medium (2.28-6.57 μmol/L), and high levels (>6.57 μmol/L) based on the 25th and 75th percentile. Associations of TMAO with recurrent VTE, major or non-major bleeding, and mortality were investigated.
RESULTS
During a mean follow-up of 28 months, 106 patients developed recurrent VTE, 259 had major or non-major bleeding events, and 179 patients died. The risk of recurrent VTE did not differ significantly between patients with low, medium (adjusted subhazard ratio [SHR], 1.38; 95% confidence interval [CI], 0.81 to 2.36; p = 0.232) and high TMAO levels (SHR, 1.44; 95% CI, 0.80 to 2.58, p = 0.221). Compared with low TMAO levels, the adjusted hazard ratio [HR] for mortality was 0.68 (95% CI, 0.47 to 0.98, p = 0.039) in patients with medium TMAO levels and 1.02 (95% CI, 0.68 to 1.52, p = 0.922) in patients with high TMAO levels. Fractional polynomial Cox-regression confirmed a U-shaped association (adjusted p = 0.045), with the lowest mortality risk in patients with TMAO around 4 μmol/L. TMAO was not associated with major or non-major bleeding.
CONCLUSION
TMAO showed a U-shaped association with mortality in elderly patients with acute VTE and was not associated with recurrent VTE and major or non-major bleeding.
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) correlates with arterial thrombotic events including myocardial infarction and stroke, and mortality. However, the association of TMAO with recurrent venous thromboembolism (VTE) and mortality remains unknown.
METHODS
TMAO plasma levels were assessed by high performance liquid chromatography in 859 patients aged ≥65 years with acute VTE and categorized into low (<2.28 μmol/L), medium (2.28-6.57 μmol/L), and high levels (>6.57 μmol/L) based on the 25th and 75th percentile. Associations of TMAO with recurrent VTE, major or non-major bleeding, and mortality were investigated.
RESULTS
During a mean follow-up of 28 months, 106 patients developed recurrent VTE, 259 had major or non-major bleeding events, and 179 patients died. The risk of recurrent VTE did not differ significantly between patients with low, medium (adjusted subhazard ratio [SHR], 1.38; 95% confidence interval [CI], 0.81 to 2.36; p = 0.232) and high TMAO levels (SHR, 1.44; 95% CI, 0.80 to 2.58, p = 0.221). Compared with low TMAO levels, the adjusted hazard ratio [HR] for mortality was 0.68 (95% CI, 0.47 to 0.98, p = 0.039) in patients with medium TMAO levels and 1.02 (95% CI, 0.68 to 1.52, p = 0.922) in patients with high TMAO levels. Fractional polynomial Cox-regression confirmed a U-shaped association (adjusted p = 0.045), with the lowest mortality risk in patients with TMAO around 4 μmol/L. TMAO was not associated with major or non-major bleeding.
CONCLUSION
TMAO showed a U-shaped association with mortality in elderly patients with acute VTE and was not associated with recurrent VTE and major or non-major bleeding.
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1016/j.thromres.2018.12.011
- PMID 30553164
- Persistent URL
- https://sonar.ch/global/documents/167037
Statistics
Document views: 14
File downloads:
- fulltext.pdf: 0